Dashyant Dhanak's Net Worth
$5.04 Million
Who is Dashyant Dhanak?
Dashyant Dhanak has an estimated net worth of $5.04 Million. This is based on reported shares across multiple companies, which include INCYTE CORP, and Deciphera Pharmaceuticals, Inc..
SEC CIK
Dashyant Dhanak's CIK is 0001760682
Past Insider Trading and Trends
2020 was Dashyant Dhanak's most active year for acquiring shares with 14 total transactions. Dashyant Dhanak's most active month to acquire stocks was the month of June. 2020 was Dashyant Dhanak's most active year for disposing of shares, totalling 19 transactions. Dashyant Dhanak's most active month to dispose stocks was the month of May. 2021 saw Dashyant Dhanak paying a total of $314,408.52 for 43,190 shares, this is the most they've acquired in one year. In 2023 Dashyant Dhanak cashed out on 12,156 shares for a total of $580,826.52, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INCYTE CORP (INCY) Snapshot price: $60.96
EVP & Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +15.82% | 8.06K |
—
|
—
| 58.97K |
Jul 14
| |||
Form 4
| -10.61% | -6.04K |
$62.08 | -$375,211.52 | 50.91K |
Jul 3
| |||
Form 4
| +6.93% | 3.69K |
$65.42 | $241,596.06 | 56.96K |
Feb 16
| |||
Form 4
| -4.34% | -2.42K |
$85.00 | -$205,615.00 | 53.26K |
Scheduled
|
Jan 26
| ||
Form 4
| +9.82% | 4.98K |
—
|
—
| 55.68K |
Jan 20
| |||
Form 4
| -1.04% | -533.00 |
$82.36 | -$43,897.88 | 50.7K |
Dec 12
| |||
Form 4
| +21.58% | 9.09K |
$79.25 | -$172,844.25 | 51.23K |
Jul 2 - Jul 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
| +25.93% | 8.68K |
—
|
—
| 42.14K |
Jan 1
| |||
Form 4
| -1.57% | -533.00 |
$65.40 | -$34,858.20 | 33.46K |
Dec 10
| |||
Form 4
| +8.75% | 2.73K |
—
|
—
| 34K |
Nov 19
| |||
Form 4
| -1.23% | -389.00 |
$68.67 | -$26,712.63 | 31.26K |
Scheduled
|
Oct 1
| ||
Form 4
| -1.21% | -388.00 |
$76.71 | -$29,763.48 | 31.65K |
Scheduled
|
Sep 1
| ||
Form 4
| -1.20% | -389.00 |
$77.49 | -$30,143.61 | 32.04K |
Scheduled
|
Aug 2
| ||
Form 4
| +24.02% | 6.28K |
$83.58 | -$131,471.34 | 32.43K |
Jul 2
| |||
Form 4
| -1.49% | -396.00 |
$84.09 | -$33,299.64 | 26.15K |
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
$76.21 | -$82,975.10 | 26.55K |
Scheduled
|
Jun 10
| ||
Form 4
| -1.47% | -395.00 |
$84.13 | -$33,231.35 | 26.55K |
Scheduled
|
Jun 1
| ||
Form 4
| -1.45% | -396.00 |
$85.40 | -$33,818.40 | 26.94K |
Scheduled
|
May 3
| ||
Form 4
| -1.43% | -396.00 |
$81.57 | -$32,301.72 | 27.34K |
Scheduled
|
Apr 1
| ||
Form 4
| -1.40% | -395.00 |
$79.73 | -$31,493.35 | 27.73K |
Scheduled
|
Mar 1
| ||
Form 4
| -1.38% | -395.00 |
$77.71 | -$59,171.38 | 28.13K |
Scheduled
|
Feb 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
| -2.46% | -720.00 |
$82.05 | -$59,076.00 | 28.52K |
Dec 10
| |||
Form 4
| +4.40% | 1.23K |
—
|
—
| 29.24K |
Nov 16
| |||
Form 4
|
—
|
0
|
$75.30 | -$18,979.75 | 28.01K |
Scheduled
|
Nov 6
| ||
Form 4
|
—
|
0
|
$78.69 | -$25,514.55 | 28.01K |
Scheduled
|
Oct 6
| ||
Form 4
|
—
|
0
|
$77.18 | -$22,602.72 | 28.01K |
Scheduled
|
Sep 8
| ||
Form 4
|
—
|
0
|
$81.61 | -$31,117.18 | 28.01K |
Scheduled
|
Aug 6
| ||
Form 4
| +9.45% | 2.42K |
$65.42 | $158,250.98 | 28.01K |
Jul 13
| |||
Form 4
| +28.04% | 5.6K |
$85.97 | -$152,093.55 | 25.59K |
Scheduled
|
Jul 2 - Jul 6
| ||
Form 4
|
—
|
0
|
$78.65 | -$25,418.45 | 19.99K |
Scheduled
|
Jun 8
| ||
Form 4
|
—
|
0
|
$81.13 | -$30,194.62 | 19.99K |
Scheduled
|
May 6
| ||
Form 4
|
—
|
0
|
$75.21 | -$75,265.52 | 19.99K |
Scheduled
|
Apr 6
| ||
Form 4
| +52.50% | 6.88K |
—
|
—
| 19.99K |
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
| -3.91% | -533.00 |
$95.72 | -$51,018.76 | 13.11K |
Dec 10
| |||
Form 4
| +98.30% | 6.76K |
—
|
—
| 13.64K |
Jul 2
| |||
Form 4
|
∞
| 6.88K |
—
|
—
| 6.88K |
Dec 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Deciphera Pharmaceuticals, Inc. (DCPH) No price found
EVP & Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -158.18K |
—
|
—
|
0
|
Jun 11
| |||
Form 4
| +12.26% | 17.27K |
—
|
—
| 158.18K |
Feb 15
| |||
Form 4
|
∞
| 140.9K |
—
|
—
| 140.9K |
Sep 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |